Pricing Log in Create free account

Puma Biotechnology, Inc. (PBYI) vs Valneva SE Sponsored ADR (VALN)

Puma Biotechnology, Inc. and Valneva SE Sponsored ADR are both Biotechnology companies. Puma Biotechnology, Inc. and Valneva SE Sponsored ADR are of similar size ($560.4M and $543.0M). Puma Biotechnology, Inc. trades at the lower P/E: 18.2× against 59.7×. Puma Biotechnology, Inc. grew revenue faster over the last twelve months: −2.86% against −53.2%. Puma Biotechnology, Inc. has the higher net margin (11.6% vs −12.0%) and the higher return on invested capital (42.6% vs 0.00%). Across the 20 metrics below, Puma Biotechnology, Inc. leads on 18 and Valneva SE Sponsored ADR on 2.

Valuation

Metric PBYI VALN Biotechnology median
P/E 18.20 59.68 8.50
P/S 2.17 3.05 9.71
P/B 3.61 5.30 2.13
Price to free cash flow 17.52 n/m 20.82
EV/EBITDA 10.48 42.91 0.64
EV/Sales 1.86 3.49 9.21
Earnings yield 5.49% 1.68% (33.15%)
Free cash flow yield 5.71% (11.78%) (25.50%)

Profitability

Metric PBYI VALN Biotechnology median
Gross margin 74.83% 38.28% 65.16%
Operating margin 13.16% 13.56% 0.00%
Net margin 11.55% (12.01%) 0.00%
Free cash flow margin 17.79% 0.00% 0.00%
Return on equity 21.97% 0.00% (56.36%)
Return on assets 13.78% 0.00% (48.04%)
Return on invested capital 42.61% 0.00% 0.00%

Growth

Metric PBYI VALN Biotechnology median
Revenue growth (TTM) (2.86%) (53.16%) 6.02%
EPS growth (last fiscal year) (1.61%) (805.88%) 30.26%
Revenue growth, 5-year CAGR 0.29% 9.41% 9.41%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric PBYI VALN Biotechnology median
Debt to equity 0.00 2.27 0.00
Current ratio 2.91 2.16 4.72
Net debt to EBITDA (1.60) (1.15) 0.96

Dividend

Metric PBYI VALN Biotechnology median
Dividend yield — — 0.09%
Payout ratio — — —

Size

Metric PBYI VALN Biotechnology median
Market cap 543.04m 560.39m 135.18m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack